AOD

AOD (AOD-9604) is a synthetic peptide derived from the C-terminal lipolytic region of human growth hormone (hGH). It’s commonly used in research to investigate fat metabolism signaling, particularly pathways involved in lipolysis (fat breakdown) and lipogenesis (fat storage)—as a way to study GH-fragment activity without full-length GH receptor signaling.

• Research class: Synthetic 16–amino-acid hGH-fragment analog (derived from the hGH C-terminus).

• Primary research purpose: Studying adipose metabolism signaling (lipolysis activation and lipogenesis inhibition endpoints reported in preclinical literature).

• Mechanistic focus (research): Explored for non-classical GH-fragment actions (reported not to bind the GH receptor in key studies), with investigation into downstream lipid-handling pathways.

• Common research endpoints: Fat oxidation markers, adipocyte lipid content changes, lipid-metabolism biomarker panels, and pathway-level expression changes associated with lipid handling.

For research use only. Not for therapeutic or diagnostic applications.